Vyzkoušejte nový nástroj s podporou AI
Summon Research Assistant
BETA
Abstract 6387: Oral and selective ribonucleotide reductase (RNR) inhibitor, BBI-825, suppresses acquired resistance to mutant-specific, pan, and multi-RAS targeting inhibitors
Lange, Joshua, Garcia, Salvador, Holmes, Evan, Pferdekamper, AnneMarie, Norman, Ben, Steffy, Auzon, Plum, Joshua, Catalano, Nicholas, DuPai, Cory, Zhao, HuiYong, de Stanchina, Elisa, Kuelbs, Claire, Christofferson, Austin, Ardeshiri, Ardalan, Tse, Edison, Derheimer, Frederick, Chen, Joan, Liao, Debbie, Hansen, Ryan, Yaeger, Rona, Chowdhry, Sudhir, Hassig, Christian
Published in Cancer research (Chicago, Ill.) (21.04.2025)
Published in Cancer research (Chicago, Ill.) (21.04.2025)
Get full text
Journal Article
Abstract 613: Oral CHK1 inhibitor BBI-355 allows flexibility of dose and schedule with demonstration of monotherapy and combinational antitumor activity in extrachromosomal DNA (ecDNA) driven preclinical models
Hansen, Ryan J., Steffy, Auzon, Plum, Joshua, Ardeshiri, Ardalan, Tse, Edison, Garcia, Salvador, Norman, Ben, Moininazeri, Jafar, Pferdekamper, AnneMarie, Holmes, Evan, Liao, Debbie, Elsdon, Rachelle, Lange, Joshua, Pinkerton, Anthony, Apuy, Julius, Chowdhry, Sudhir, Hassig, Christian, Kasibhatla, Shailaja
Published in Cancer research (Chicago, Ill.) (22.03.2024)
Published in Cancer research (Chicago, Ill.) (22.03.2024)
Get full text
Journal Article
Abstract B082: A novel, potent and selective ribonucleotide reductase (RNR) inhibitor, BBI-825, blocks extrachromosomal DNA (ecDNA) amplification-mediated resistance to KRASG12C inhibitor in colorectal cancer (CRC)
Chowdhry, Sudhir, Hansen, Ryan, Mauger, Jacques, Pferdekamper, AnneMarie, Tse, Edison, Norman, Ben, Moininazeri, Jafar, Garcia, Salvador, Truong, Yen, Liao, Debbie, Lange, Joshua, Holmes, Evan, Celeste, Anthony, Solis, Dave, Steffy, Auzon, Plum, Joshua, Wiese, Julie, Apuy, Julius, Ardeshiri, Ardalan, Milutinovic, Snezana, Wilkinson, Deepti, Pinkerton, Anthony, Hassig, Christian, Kasibhatla, Shailaja
Published in Molecular cancer therapeutics (01.12.2023)
Published in Molecular cancer therapeutics (01.12.2023)
Get full text
Journal Article
Ischemic insult to cerebellar Purkinje cells causes diminished GABA A receptor function and allopregnanolone neuroprotection is associated with GABA A receptor stabilization
Kelley, Melissa H., Taguchi, Noriko, Ardeshiri, Ardalan, Kuroiwa, Masayuki, Hurn, Patricia D., Traystman, Richard J., Herson, Paco S.
Published in Journal of neurochemistry (01.11.2008)
Published in Journal of neurochemistry (01.11.2008)
Get full text
Journal Article
Ischemic insult to cerebellar Purkinje cells causes diminished GABA sub(A) receptor function and allopregnanolone neuroprotection is associated with GABA sub(A) receptor stabilization
Kelley, Melissa H, Taguchi, Noriko, Ardeshiri, Ardalan, Kuroiwa, Masayuki, Hurn, Patricia D, Traystman, Richard J, Herson, Paco S
Published in Journal of neurochemistry (01.11.2008)
Published in Journal of neurochemistry (01.11.2008)
Get full text
Journal Article
Ischemic insult to cerebellar Purkinje cells causes diminished GABAA receptor function and allopregnanolone neuroprotection is associated with GABAA receptor stabilization
Kelley, Melissa H, Taguchi, Noriko, Ardeshiri, Ardalan, Kuroiwa, Masayuki, Hurn, Patricia D, Traystman, Richard J, Herson, Paco S
Published in Journal of neurochemistry (01.11.2008)
Published in Journal of neurochemistry (01.11.2008)
Get full text
Journal Article